Ajit P Limaye
Overview
Explore the profile of Ajit P Limaye including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
176
Citations
3556
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Heldman M, Boeckh M, Limaye A
Clin Infect Dis
. 2024 Nov;
PMID: 39492698
Successful prevention and treatment of cytomegalovirus (CMV) infection remains a central focus of clinical care in solid organ and allogeneic hematopoietic cell transplantation. Over the past 5 years, pivotal clinical...
2.
Nellore A, Houp J, Killian J, Limaye A, Fisher C
Viruses
. 2024 Oct;
16(10).
PMID: 39459908
Chronic lung allograft dysfunction (CLAD) is the most common cause of long-term lung allograft failure. Several factors, including respiratory virus infection (RVI), have been associated with CLAD development, but the...
3.
Imlay H, Gnann Jr J, Rooney J, Peddi V, Wiseman A, Josephson M, et al.
Transpl Infect Dis
. 2024 Sep;
26(6):e14367.
PMID: 39226143
Background: BK polyomavirus-associated nephropathy (BKPyVAN) is an important cause of allograft dysfunction and failure in kidney transplant recipients (KTRs) and there are no proven effective treatments. Case reports and in...
4.
Zamora D, Dasgupta S, Stevens-Ayers T, Edmison B, Winston D, Razonable R, et al.
JCI Insight
. 2024 Aug;
9(18).
PMID: 39099206
CMV-specific T cells, NK cells, and neutralizing antibodies (nAbs) were assessed in a randomized trial of CMV prevention with preemptive antiviral therapy (PET) versus prophylactic antiviral therapy (PRO) in donor-seropositive/recipient-seronegative...
5.
Ljungman P, Chemaly R, Khawaya F, Alain S, Avery R, Badshah C, et al.
Clin Infect Dis
. 2024 Jul;
79(3):787-794.
PMID: 39041385
Cytomegalovirus (CMV) infection and disease are important causes of morbidity and mortality in transplant recipients. For the purpose of developing consistent reporting of CMV outcomes in clinical trials, definitions of...
6.
Fischer M, Green M, Selke S, Limaye A, Wald A, Boeckh M, et al.
Transpl Infect Dis
. 2024 Jul;
26(4):e14335.
PMID: 39010324
Background: Herpes simplex viruses (HSVs) frequently reactivate during immunosuppression and may be a risk factor for adverse outcomes after solid organ transplant (SOT). While suppressive antiviral therapy reduces the risk...
7.
Boeckh M, Pergam S, Limaye A, Englund J, Corey L, Hill J
Clin Infect Dis
. 2024 Jun;
79(4):1018-1023.
PMID: 38825885
The immunocompromised population was disproportionately affected by the severe acute respiratory syndrome coronavirus 2 pandemic. However, these individuals were largely excluded from clinical trials of vaccines, monoclonal antibodies, and small...
8.
Phan T, Kumar L, Woo M, Sadowska-Klasa A, Castor J, Pepper G, et al.
Microbiol Spectr
. 2024 May;
12(7):e0003024.
PMID: 38771037
Importance: We evaluate an FDA-cleared blood self-collection device (Tasso+) and demonstrate that it is patient-acceptable and yields a liquid blood sample with quantitative CMV DNAemia results comparable to those of...
9.
Joncas-Schronce L, Ali F, Pepper G, Stapleton R, Rubenfeld G, Boeckh M, et al.
Open Forum Infect Dis
. 2024 Mar;
11(3):ofae084.
PMID: 38481427
Background: Cytomegalovirus (CMV) serostatus is a major determinant of CMV infection, disease risk, and transplant outcomes. Current clinical serology assays are limited by relatively slow turnaround time, design for batched...
10.
Heldman M, Dunn B, Clemens E, Henderson M, Fisher C, Rakita R, et al.
Transpl Infect Dis
. 2024 Jan;
26(3):e14229.
PMID: 38214192
The Comparison of Antiviral Preventative Strategies In Liver Transplant (CAPSIL) study showed pre-emptive therapy (PET) to be superior to antiviral prophylaxis for Cytomegalovirus (CMV) disease prevention in high-risk CMV seronegative...